Premium
Zolpidem test and catatonia
Author(s) -
Javelot H.,
Michel B.,
Steiner R.,
Javelot T.,
Cottencin O.
Publication year - 2015
Publication title -
journal of clinical pharmacy and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.622
H-Index - 73
eISSN - 1365-2710
pISSN - 0269-4727
DOI - 10.1111/jcpt.12330
Subject(s) - zolpidem , lorazepam , catatonia , schizophrenia (object oriented programming) , dosing , electroconvulsive therapy , medicine , antipsychotic , paranoid schizophrenia , psychology , anesthesia , psychiatry , psychosis , pharmacology , insomnia
Summary What is known and objective There is no consensus regarding treatment of catatonia and the main recent therapeutic progress has been the development of the zolpidem diagnostic and therapeutic test. We report on the use of this test in one of our patients. Cases summary Mr. S. suffered from a paranoid schizophrenia. Three episodes of catatonia are described to illustrate the effect of zolpidem in a patient for whom lorazepam was ineffective or inadequate. What is new and conclusion Zolpidem with appropriate testing appears to be a credible alternative to electroconvulsive therapy or increased lorazepam dosing and allows continuation of antipsychotic administration.